A rapid increase in macrophage-derived versican and hyaluronan in infectious lung disease
about
Macrophages: Regulators of the Inflammatory Microenvironment during Mammary Gland Development and Breast CancerHyaluronan: A Mediator of Islet Dysfunction and Destruction in Diabetes?Eighth symposium on biologic scaffolds for regenerative medicineHyaluronan fragments as mediators of inflammation in allergic pulmonary diseaseExpression of V3 Versican by Rat Arterial Smooth Muscle Cells Promotes Differentiated and Anti-inflammatory PhenotypesToll-like Receptors in the Vascular System: Sensing the Dangers Within.Soluble biglycan: a potential mediator of cartilage degradation in osteoarthritisCorrelation of Versican Expression, Accumulation, and Degradation during Embryonic Development by Quantitative ImmunohistochemistryBinding of Hyaluronan to the Native Lymphatic Vessel Endothelial Receptor LYVE-1 Is Critically Dependent on Receptor Clustering and Hyaluronan OrganizationSubepithelial Accumulation of Versican in a Cockroach Antigen-Induced Murine Model of Allergic Asthma.Provisional matrix: A role for versican and hyaluronan.Interplay of extracellular matrix and leukocytes in lung inflammation.Stromelysin-2 (MMP10) Moderates Inflammation by Controlling Macrophage Activation.Versican is Produced by Trif- and Type I Interferon-Dependent Signaling in Macrophages and Contributes to Fine-Control of Innate Immunity in Lungs.Versican Deficiency Significantly Reduces Lung Inflammatory Response Induced by Polyinosine-Polycytidylic Acid Stimulation.Proteoglycans as Immunomodulators of the Innate Immune Response to Lung Infection.Dendritic cells enter lymph vessels by hyaluronan-mediated docking to the endothelial receptor LYVE-1.Transmembrane Pickets Connect Cyto- and Pericellular Skeletons Forming Barriers to Receptor Engagement.Danger-Associated Molecular Patterns Derived From the Extracellular Matrix Provide Temporal Control of Innate Immunity.Hyaluronan interactions with innate immunity in lung biology.Rapid clearance of heavy chain-modified hyaluronan during resolving acute lung injury.
P2860
Q26765377-28B385F5-29D5-4C33-AC54-4074B81502CEQ26799151-2855B2E3-4B0A-42C9-9014-66E5901050BBQ34679127-F4962798-0636-4EC5-B59A-4461482C7EB0Q35370946-4A92B423-B1C6-4DC5-AC7C-C2394F181AF2Q36065126-1986DB22-4F10-4D4E-B04A-5843A8E56742Q36453194-12C81A0E-4A92-43EE-B955-DD7B83C055B8Q36477482-DD2A05B5-ADFD-4319-89F4-F23E38B758E2Q36774513-D129352C-BCB1-4578-9B6A-4404637F5B9FQ36778808-F86648C4-1B6C-48A7-A38D-3ADAB1CB577FQ36954958-F61BA853-9350-4EDB-987C-11DFAEF27084Q39033619-97CD65AC-7A18-4A00-A7F5-7B2D455B6C22Q39080263-2B08C441-37E5-48E8-93BF-E0038311656BQ39674436-83410C1A-F242-4069-8D91-FB41BCEA8FF9Q40045079-01AEBE84-D131-41BA-94CD-0800476852E2Q40432439-DBFF4135-FC4B-47F7-B82D-34EAFBA3752AQ47719302-1B9686D8-7F05-4515-96B8-E778AB5C8B84Q48144529-CE7AAF66-6F2E-4C14-8248-525BBA3F1FF6Q48507720-099308AA-DDB0-4073-96B3-04508FFB72A1Q49382014-D24D4547-83CE-4175-A675-EA4C2C4459CDQ50150200-1D57B650-418B-4662-99BF-C5A258F1B5BAQ55353966-BA597140-2178-412A-A584-1D1F325DEA03
P2860
A rapid increase in macrophage-derived versican and hyaluronan in infectious lung disease
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A rapid increase in macrophage-derived versican and hyaluronan in infectious lung disease
@ast
A rapid increase in macrophage-derived versican and hyaluronan in infectious lung disease
@en
type
label
A rapid increase in macrophage-derived versican and hyaluronan in infectious lung disease
@ast
A rapid increase in macrophage-derived versican and hyaluronan in infectious lung disease
@en
prefLabel
A rapid increase in macrophage-derived versican and hyaluronan in infectious lung disease
@ast
A rapid increase in macrophage-derived versican and hyaluronan in infectious lung disease
@en
P2093
P2860
P1433
P1476
A rapid increase in macrophage-derived versican and hyaluronan in infectious lung disease
@en
P2093
Charles W Frevert
Christina K Chan
Mary Y Chang
Michael G Kinsella
Pamela Y Johnson
Thomas N Wight
Veronika Vidova
P2860
P356
10.1016/J.MATBIO.2014.01.011
P577
2014-01-26T00:00:00Z